Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Microbiology|October 13, 2022
In vivo Phage Display: A promising selection strategy for the improvement of antibody targeting and drug delivery propertiesAna S André, Isa Moutinho, Joana N R Dias, et al.
Frontiers in Veterinary Science|September 13, 2021
Immunotherapeutic Strategies for Canine Lymphoma: Changing the Odds Against Non-Hodgkin LymphomaJoana N R Dias, Ana S André, Sandra I Aguiar, et al.
Scientific Reports|February 18, 2022
Characterization of the canine CD20 as a therapeutic target for comparative passive immunotherapyJoana N R Dias, André Almeida, Ana S André, et al.
Plos One|December 29, 2018
Establishment of a bioluminescent canine B-cell lymphoma xenograft model for monitoring tumor progression and treatment response in preclinical studiesJoana N R Dias, Ana S André, Sandra I Aguiar, et al.
Angewandte Chemie (International Ed. in English)|November 6, 2021
Diazaborines Are a Versatile Platform to Develop ROS-Responsive Antibody Drug Conjugates*João P M António, Joana Inês Carvalho, Ana S André, et al.
Oncotarget|July 10, 2018
The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphomaJoana N R Dias, Sandra I Aguiar, Diane M Pereira, et al.
Frontiers in Veterinary Science|April 21, 2025
A new treatment for canine B-cell lymphoma based on a recombinant single-domain antibody immunotoxin derived from Pseudomonas aeruginosa exotoxin AAna S André, Joana N R Dias, Isa Moutinho, et al.
Frontiers in Veterinary Science|September 15, 2023
Panobinostat-loaded folate targeted liposomes as a promising drug delivery system for treatment of canine B-cell lymphomaAna S André, Joana N R Dias, Sandra I Aguiar, et al.
Scientific Reports|March 25, 2023
Rabbit derived VL single-domains as promising scaffolds to generate antibody-drug conjugatesAna S André, Joana N R Dias, Sandra Aguiar, et al.
Pageof 1